Contents
Special Issue Topic

The HPA Axis in Health and Disease

Submission Deadline: July 02, 2025

Guest Editor

Charlotte Steenblock E-Mail

Research group leader at the Dept. of Internal Medicine III, University Clinic Carl Gustav Carus, TU Dresden, Germany.

Research Keywords: diabetes mellitus type 1; metabolism; adrenal; endocrine stem cells

About the Special lssue

The endocrine stress system comprises the hypothalamus, pituitary gland, and adrenal gland, which collectively form the HPA axis. The hypothalamus acts as a central relay to control the endocrine response of the pituitary and adrenal glands. While a proper stress response is necessary for survival, stress is also linked to various disorders, such as depression, anxiety, and post-traumatic stress disorder. Research suggests that early life stress or maltreatment may increase the risk of developing major psychiatric disorders, substance and alcohol abuse, and medical conditions like diabetes in adulthood. Dysregulation of the endocrine stress axis has been observed in studies on depressed adult men and women with early life stress. Stress-induced changes in the stress axis activity are influenced by genetic predisposition and epigenetic factors. Despite extensive research into proper regulation and possible dysregulation of the endocrine stress axis in health and disease, the biological mechanisms underlying increased vulnerability to disease after stress are still not fully understood. We are collecting original research and review articles from experts in the field to further our understanding of how the HPA axis is regulated in both health and disease.

Keywords: HPA axis; hypothalamus; pituitary; adrenal; stress; epigenetics; signalling

Published Articles

Open Access Review
Hypothetical involvement of stress hormones-induced reprograming of adult stem/progenitor cells in tumorigenesis
Stress is a state of threatened or perceived as threatened homeostasis that can be induced by various external and internal stimuli such as psychosocial factors, inflammatory or injurious conditions
Published: July 15, 2024 Explor Endocr Metab Dis. 2024;1:122–157
1583 17 0
Open Access Review
Genome editing in the adrenal gland: a novel strategy for treating congenital adrenal hyperplasia
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency leads to high morbidity and mortality, despite the availability of life-saving corticosteroid replacement therapy. Gene therapy repres
Published: July 09, 2024 Explor Endocr Metab Dis. 2024;1:101–121
2339 49 0
Open Access Original Article
Epigenetics in etiopathology of hyperprolactinemia
Aim: Epigenetic alterations have been reported in patients with pituitary tumors and those on antipsychotic drugs, which are also responsible for hyperprolactinemia. This suggests a possible role
Published: May 22, 2024 Explor Endocr Metab Dis. 2024;1:39–55
1547 18 0
Completed Special Issues